Cargando…
Inhibition of Glycoprotein VI Clustering by Collagen as a Mechanism of Inhibiting Collagen-Induced Platelet Responses: The Example of Losartan
Exposure of platelets to collagen triggers the formation of a platelet clot. Pharmacological agents capable of inhibiting platelet activation by collagen are thus of potential therapeutic interest. Thrombus formation is initiated by the interaction of the GPIb-V-IX complex with collagen-bound vWF, w...
Autores principales: | Jiang, Peng, Loyau, Stéphane, Tchitchinadze, Maria, Ropers, Jacques, Jondeau, Guillaume, Jandrot-Perrus, Martine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460036/ https://www.ncbi.nlm.nih.gov/pubmed/26052700 http://dx.doi.org/10.1371/journal.pone.0128744 |
Ejemplares similares
-
Collagen Can Selectively Trigger a Platelet Secretory Phenotype via Glycoprotein VI
por: Ollivier, Véronique, et al.
Publicado: (2014) -
Non-Invasive Molecular Imaging of Fibrosis Using a Collagen-Targeted Peptidomimetic of the Platelet Collagen Receptor Glycoprotein VI
por: Muzard, Julien, et al.
Publicado: (2009) -
Population Pharmacokinetic/Pharmacodynamic Modeling of Glenzocimab (ACT017) a Glycoprotein VI Inhibitor of Collagen‐Induced Platelet Aggregation
por: Renaud, Lionel, et al.
Publicado: (2020) -
Immobilized fibrinogen activates human platelets through glycoprotein VI
por: Mangin, Pierre H, et al.
Publicado: (2018) -
Glycoprotein VI in securing vascular integrity in inflamed vessels
por: Boulaftali, Yacine, et al.
Publicado: (2018)